Assessing the impact of national antibiotic campaigns in Europe
Open accessAbstract
Because of evidence of causal association between antibiotic use and bacterial resistance, the implementation of national policies has emerged as a interesting tool for controlling and reversing bacterial resistance. The aim of this study was to assess the impact of public policies on antibiotic use in Europe using a differences-in-differences approach. Comparable data on systemic antibiotics administered in 21 European countries are available for a 11-year period between 1997 and 2007. Data on national campaigns are drawn from the public health literature. We estimate an econometric model of antibiotic consumption with country fixed effects and control for the main socioeconomic and epidemiological factors. Lagged values and the instrumental variables approach are applied to address endogeneity aspects of the prevalence of infections and the adoption of national campaigns. We find evidence that public campaigns significantly reduce the use of antimicrobials in the community by 1.3-5.6 defined daily doses per 1,000 inhabitants yearly. This represents an impact of roughly 6.5-28.3 % on the mean level of antibiotic use in Europe between 1997 and 2007. The effect is robust across different measurement methods. Further research is needed to investigate the effectiveness of policy interventions targeting different social groups such as general practitioners or patients.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Cites
How Much Should We Trust Differences-in-Differences Estimates?
Bertrand, M., Duflo, E., & Mullainathan, S. (2004) · The Quarterly Journal of Economics · doi:10.1162/003355304772839588 · Cited by 10,641 · see citing works
Microeconometrics: Methods and Applications
Cameron, A. C., & Trivedi, P. K. (2005) · doi:10.1017/cbo9780511811241 · Cited by 8,092 · see citing works
Danaei, G., Ding, E. L., Mozaffarian, D., Taylor, B., Rehm, J., Murray, C. J. L., & Ezzati, M. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000058 · Cited by 2,860 · see citing works
PRACTITIONERS’ CORNER: Computing Robust Standard Errors for Within‐groups Estimators *
Arellano, M. (1987) · Oxford Bulletin of Economics and Statistics · doi:10.1111/j.1468-0084.1987.mp49004006.x · Cited by 1,456 · see citing works
Huttner, B. D., Goossens, H., Verheij, T. J., & Harbarth, S. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70305-6 · Cited by 573 · see citing works
Antimicrobial Drug Use and Resistance in Europe
van de Sande-Bruinsma, N., Grundmann, H., Verloo, D., Tiemersma, E. W., Monen, J., Goossens, H., Ferech, M., & the European Antimicrobial Resistance Surveillance System and European Surveillance of Antimicrobial Consumption Project Groups (2008) · Emerging infectious diseases · doi:10.3201/eid1411.070467 · Cited by 481 · see citing works
Economic and political liberalizations
Giavazzi, F., & Tabellini, G. (2005) · Journal of Monetary Economics · doi:10.1016/j.jmoneco.2005.05.002 · Cited by 424 · see citing works
Sabuncu, E., David, J., Bernède‐Bauduin, C., Pépin, S., Leroy, M., Boëlle, P., Watier, L., & Guillemot, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000084 · Cited by 404 · see citing works
Finite-Sample Properties of Propensity-Score Matching and Weighting Estimators
Frölich, M. (2004) · The Review of Economics and Statistics · doi:10.1162/003465304323023697 · Cited by 404 · see citing works
Antibiotic Selection Pressure and Resistance in Streptococcus pneumoniae and Streptococcus pyogenes
Albrich, W. C., Monnet, D. L., & Harbarth, S. (2004) · Emerging infectious diseases · doi:10.3201/eid1003.030252 · Cited by 374 · see citing works
Robust Standard Error Estimation in Fixed-Effects Panel ModelsPreprint
Kézdi, G. (2004) · SSRN Electronic Journal · doi:10.2139/ssrn.596988 · Cited by 347 · see citing works
A Primer for Applying Propensity-Score Matching
Heinrich, C. J., Maffioli, A., & Vázquez, G. (2010) · doi:10.18235/0008567 · Cited by 280 · see citing works
Matteo, L. D. (2004) · Health Policy · doi:10.1016/j.healthpol.2004.05.007 · Cited by 221 · see citing works
Deschepper, R., Grigoryan, L., Lundborg, C. S., et al. (2008) · BMC Health Services Research · doi:10.1186/1472-6963-8-123 · Cited by 211 · see citing works
National campaigns to improve antibiotic use
Goossens, H., Guillemot, D., Ferech, M., Schlemmer, B., Costers, M., van Breda, M., Baker, L. J., Cars, O., & Davey, P. G. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0094-7 · Cited by 210 · see citing works
The use and resistance to antibiotics in the community
Čižman, M. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00394-1 · Cited by 189 · see citing works
Self-medication with antibiotics—Does it really happen in Europe?
Väänänen, M. H., Pietilä, K., & Airaksinen, M. (2005) · Health Policy · doi:10.1016/j.healthpol.2005.07.001 · Cited by 186 · see citing works
The Sale of Antibiotics without Prescription in Pharmacies in Catalonia, Spain
Llor, C., & Cots, J. M. (2009) · Clinical Infectious Diseases · doi:10.1086/598183 · Cited by 176 · see citing works
Filippini, M., Masiero, G., & Moschetti, K. (2005) · Health Policy · doi:10.1016/j.healthpol.2005.09.009 · Cited by 172 · see citing works
Self-citationHarbarth, S., Albrich, W. C., & Brun‐Buisson, C. (2002) · Emerging infectious diseases · doi:10.3201/eid0812.010533 · Cited by 155 · see citing works
Antibiotic Prescription Rates Vary Markedly Between 13 European Countries
Mölstad, S., Lundborg, C. S., Karlsson, A.-K., et al. (2002) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540110080034 · Cited by 127 · see citing works
Stichele, R. V., Elseviers, M. M., Ferech, M., Blot, S. I., Goossens, H., & the ESAC Project Group (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02164.x · Cited by 126 · see citing works
Antibiotic use following a Korean national policy to prohibit medication dispensing by physicians
Park, S., Soumerai, S. B., Adams, A. S., Finkelstein, J. A., Jang, S., & Ross-Degnan, D. (2005) · Health Policy and Planning · doi:10.1093/heapol/czi033 · Cited by 107 · see citing works
Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC)
Goossens, H., Coenen, S., Costers, M., Corte, S. D., Sutter, A., Gordts, B., Laurier, L., & Struelens, M. J. (2008) · Eurosurveillance · doi:10.2807/ese.13.46.19036-en · Cited by 98 · see citing works
Borg, M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr541 · Cited by 88 · see citing works
Socioeconomic determinants of outpatient antibiotic use in Europe
Masiero, G., Filippini, M., Ferech, M., & Goossens, H. (2010) · International Journal of Public Health · doi:10.1007/s00038-010-0167-y · Cited by 86 · see citing works
Self-citationAn economic perspective on policy to reduce antimicrobial resistance
Coast, J., Smith, R., & Millar, M. R. (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(97)00132-9 · Cited by 86 · see citing works
Antibiotics in the community: A typology of user behaviours
Hawkings, N. J., Butler, C., & Wood, F. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2008.05.025 · Cited by 80 · see citing works
Polypharmacy in general practice: differences between practitioners.
Bjerrum, L., Søgaard, J., Hallas, J., et al. (1999) · PubMed · Cited by 71 · see citing works
Quick, J. D., Laing, R. O., & Ross‐Degnan, D. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90114-o · Cited by 59 · see citing works
Use of Antimicrobial Agents in Consumer Products
Tan, L. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.8.1082 · Cited by 57 · see citing works
Economic implications of antibiotic resistance in a global economy
Rudholm, N. (2002) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00053-x · Cited by 56 · see citing works
Chahwakilian, P., Huttner, B. D., Schlemmer, B., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr387 · Cited by 56 · see citing works
Demand systems and the true subindex of the cost of living for pharmaceuticals
Baye, M. R., Maness, R., & Wiggins, S. N. (1997) · Applied Economics · doi:10.1080/00036849700000009 · Cited by 33 · see citing works
Antibiotic policies in Central Eastern Europe
Čižman, M., Beovič, B., Krcmery, V., et al. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.03.016 · Cited by 26 · see citing works
Small area variations and welfare loss in the use of outpatient antibiotics
Filippini, M., Masiero, G., & Moschetti, K. (2008) · Health Economics Policy and Law · doi:10.1017/s174413310800460x · Cited by 23 · see citing works
Self-citationPatient Satisfaction, Doctor Effort, And Interview Location : Evidence From Paraguay
Sohnesen, T. P., & Das, J. (2006) · World Bank, Washington, DC eBooks · doi:10.1596/1813-9450-4086 · Cited by 17 · see citing works
Regional consumption of antibiotics: A demand system approach
Filippini, M., Masiero, G., & Moschetti, K. (2009) · Economic Modelling · doi:10.1016/j.econmod.2009.07.007 · Cited by 15 · see citing works
Self-citationSabés-Figuera, R., Segú, J. L., Puig‐Junoy, J., et al. (2007) · The European Journal of Health Economics · doi:10.1007/s10198-006-0019-0 · Cited by 11 · see citing works
Federal Patent Extension, Provincial Policies, and Drug Expenditures, 1975-2000
Matteo, L. D., & Grootendorst, P. V. (2002) · Cited by 10 · see citing works
Disentangling spillover effects of antibiotic consumption: a spatial panel approach
Ortiz, L. G. G., & Masiero, G. (2011) · Applied Economics · doi:10.1080/00036846.2011.613790 · Cited by 8 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Belachew, S. A., Hall, L., Erku, D. A., & Selvey, L. A. (2021) · BMC Public Health · doi:10.1186/s12889-021-11163-3 · Cited by 73 · see citing works
- Authors
- Filippini, M., Ortiz, L. G. G., & Masiero, G.
- Affiliations
- Università della Svizzera italiana (CH)
- University of Bergamo (IT)
- Corresponding author
- Masiero, G.
- Venue
- The European Journal of Health Economics
- Published
- 2012-06-17
- Volume
- 14
- Issue
- 4
- Pages
- 587-599
- ISSN
- 1439-3972 (ISSN-L)
- 1618-7598
- 1618-7601
- OpenAlex
- W1984771562
- Cited by
- 55
- References
- 41
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 1 · 2022: 3 · 2021: 9 · 2020: 5 · 2019: 6 · 2018: 4 · 2016: 5 · 2015: 2 · 2014: 7 · 2013: 2
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- The European Journal of Health Economics (publishedVersion)
- PubMed (publishedVersion)
- reroDoc Digital Library (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Aisberg (University of Bergamo) (submittedVersion, other-oa)
- Aisberg (University of Bergamo) (submittedVersion)
- Repository for Publications and Research Data (ETH Zurich) (submittedVersion, other-oa)
- ETH Zürich Research Collection
- Topics
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
- Keywords
- antibiotic use, antimicrobial resistance, public health policy, defined daily doses, policy impact assessment, European countries
- MeSH terms
- Anti-Bacterial Agents, Europe, Health Policy, Humans, Models, Theoretical, Practice Patterns, Physicians', Program Evaluation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review